About Us  |  Contact Us  |  Español
Butler Hospital
Butler Hospital

Organizations Butler
Research Type Clinical
Therapeutic Area of Study Parkinson's Disease/Movement Disorders
Principal Investigators
Eligibility Criteria Male or female 30 years or older with early Parkinson’s disease who are not yet on treatment for Parkinson’s
Recruitment Status Open
Date Study Started 07/01/2007
Date Study Ends 07/01/2014
Contact Information

For more information contact Lisa at 401-455-6667.

Description

This study is using oral inosine to try to slow the progression of Parkinson’s disease in those with early PD. Inosine raises serum uric acid, which, by strong epidemiological evidence, is associated with reduced incidence of PD and slow progression. This study lasts approximately 2 years with 16 visits over that time period. This study is sponsored by the Michael J. Fox Foundation

Look for another study
Health Headlines
Health Tip: Keep Youngsters Outside the PoolView in a lightbox
Health Tip: Recovering After Knee ReplacementView in a lightbox
Zydelig Approved for Three Types of Blood CancerView in a lightbox
Cystic Fibrosis Drug Combo May Be Less Effective Than HopedView in a lightbox
Dangerous Use of Growth Hormone Surges Among U.S. TeensView in a lightbox
Butler Hospital
© 2011 Site Index | Disclaimer | Legal Notices